Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Consolidated Balance Sheets | ||
| Restricted cash and cash equivalents | $ 644.6 | $ 1,400.1 |
| Investments in associates, at fair value | 11,057.7 | 8,144.8 |
| Holding company cash and investments | ||
| Consolidated Balance Sheets | ||
| Assets pledged for derivative obligations | 207.8 | 193.6 |
| Portfolio investments | ||
| Consolidated Balance Sheets | ||
| Restricted cash and cash equivalents | 640.4 | 1,240.7 |
| Bonds, at cost | 39,655.2 | 37,852.9 |
| Preferred stocks, at cost | 957.4 | 944.6 |
| Common stocks, at cost | 7,926.0 | 7,116.1 |
| Investments in associates, at fair value | 11,057.7 | 8,144.8 |
| Derivatives and other invested assets, at cost | 1,312.7 | 903.9 |
| Assets pledged for derivative obligations, at cost | 187.2 | 154.8 |
| Portfolio investments | Fairfax India | ||
| Consolidated Balance Sheets | ||
| Fairfax India cash, portfolio investments and associates, at fair value | $ 3,685.1 | $ 3,163.3 |